GSK Predicts Outsourcing R&D To “Low-Cost” Countries Could Save $200 Mil.
This article was originally published in The Pink Sheet Daily
Executive Summary
Each outsourced clinical trial patient could save GSK up to $15,000, CEO Garnier estimates. The company is exploring a number of ways to control R&D costs, the exec says, citing electronic data capture as another potential option.